14 August 2026
Diranersen missed dose-response, still heads to Phase 3
In 416-patient CELIA, 60 mg every six months slowed CDR-SB decline 26% versus placebo over 18 months.
The full briefing is in the app.
14 August 2026
In 416-patient CELIA, 60 mg every six months slowed CDR-SB decline 26% versus placebo over 18 months.
The full briefing is in the app.